vs

Side-by-side financial comparison of BEAZER HOMES USA INC (BZH) and Sotera Health Co (SHC). Click either name above to swap in a different company.

BEAZER HOMES USA INC is the larger business by last-quarter revenue ($409.8M vs $303.4M, roughly 1.4× Sotera Health Co). On growth, Sotera Health Co posted the faster year-over-year revenue change (4.6% vs -47.0%). Over the past eight quarters, Sotera Health Co's revenue compounded faster (10.6% CAGR vs -28.7%).

Beazer Homes USA, Inc. is a home construction company based in Atlanta, Georgia. In 2016, the company was the 11th largest home builder in the United States based on the number of homes closed. The company operates in 13 states.

Sotera Health Co is a global provider of end-to-end medical safety solutions. It offers sterilization services, analytical laboratory testing, and regulatory advisory support for medical device manufacturers, pharmaceutical firms, and food and consumer product companies, helping clients meet industry standards and ensure product safety for end users worldwide.

BZH vs SHC — Head-to-Head

Bigger by revenue
BZH
BZH
1.4× larger
BZH
$409.8M
$303.4M
SHC
Growing faster (revenue YoY)
SHC
SHC
+51.6% gap
SHC
4.6%
-47.0%
BZH
Faster 2-yr revenue CAGR
SHC
SHC
Annualised
SHC
10.6%
-28.7%
BZH

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
BZH
BZH
SHC
SHC
Revenue
$409.8M
$303.4M
Net Profit
$34.8M
Gross Margin
11.9%
54.7%
Operating Margin
23.2%
Net Margin
11.5%
Revenue YoY
-47.0%
4.6%
Net Profit YoY
182.8%
EPS (diluted)
$-0.03
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BZH
BZH
SHC
SHC
Q2 26
$409.8M
Q1 26
$363.5M
Q4 25
$363.5M
$303.4M
Q3 25
$791.9M
$311.3M
Q2 25
$545.4M
$294.3M
Q1 25
$565.3M
$254.5M
Q4 24
$469.0M
$290.2M
Q3 24
$806.2M
$285.5M
Net Profit
BZH
BZH
SHC
SHC
Q2 26
Q1 26
Q4 25
$-32.6M
$34.8M
Q3 25
$30.0M
$48.4M
Q2 25
$-324.0K
$8.0M
Q1 25
$12.8M
$-13.3M
Q4 24
$3.1M
$12.3M
Q3 24
$52.1M
$17.0M
Gross Margin
BZH
BZH
SHC
SHC
Q2 26
11.9%
Q1 26
10.2%
Q4 25
10.2%
54.7%
Q3 25
13.5%
57.0%
Q2 25
13.3%
56.6%
Q1 25
15.2%
53.2%
Q4 24
15.4%
56.6%
Q3 24
17.5%
55.4%
Operating Margin
BZH
BZH
SHC
SHC
Q2 26
Q1 26
Q4 25
-8.8%
23.2%
Q3 25
3.1%
23.4%
Q2 25
-0.7%
6.4%
Q1 25
2.4%
-5.8%
Q4 24
0.5%
30.0%
Q3 24
7.2%
28.2%
Net Margin
BZH
BZH
SHC
SHC
Q2 26
Q1 26
Q4 25
-9.0%
11.5%
Q3 25
3.8%
15.5%
Q2 25
-0.1%
2.7%
Q1 25
2.3%
-5.2%
Q4 24
0.7%
4.2%
Q3 24
6.5%
6.0%
EPS (diluted)
BZH
BZH
SHC
SHC
Q2 26
$-0.03
Q1 26
$-1.13
Q4 25
$-1.13
$0.12
Q3 25
$1.01
$0.17
Q2 25
$-0.01
$0.03
Q1 25
$0.42
$-0.05
Q4 24
$0.10
$0.05
Q3 24
$1.69
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BZH
BZH
SHC
SHC
Cash + ST InvestmentsLiquidity on hand
$116.4M
$344.6M
Total DebtLower is stronger
$2.1B
Stockholders' EquityBook value
$1.2B
$606.0M
Total Assets
$2.8B
$3.3B
Debt / EquityLower = less leverage
3.53×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BZH
BZH
SHC
SHC
Q2 26
$116.4M
Q1 26
$120.8M
Q4 25
$120.8M
$344.6M
Q3 25
$214.7M
$299.2M
Q2 25
$82.9M
$332.4M
Q1 25
$85.1M
$304.4M
Q4 24
$80.4M
$277.2M
Q3 24
$203.9M
$306.7M
Total Debt
BZH
BZH
SHC
SHC
Q2 26
Q1 26
Q4 25
$2.1B
Q3 25
$2.1B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
$2.2B
Q3 24
$2.2B
Stockholders' Equity
BZH
BZH
SHC
SHC
Q2 26
$1.2B
Q1 26
$1.2B
Q4 25
$1.2B
$606.0M
Q3 25
$1.2B
$550.5M
Q2 25
$1.2B
$511.3M
Q1 25
$1.2B
$414.1M
Q4 24
$1.2B
$404.9M
Q3 24
$1.2B
$470.2M
Total Assets
BZH
BZH
SHC
SHC
Q2 26
$2.8B
Q1 26
$2.6B
Q4 25
$2.6B
$3.3B
Q3 25
$2.6B
$3.2B
Q2 25
$2.7B
$3.2B
Q1 25
$2.7B
$3.1B
Q4 24
$2.6B
$3.1B
Q3 24
$2.6B
$3.1B
Debt / Equity
BZH
BZH
SHC
SHC
Q2 26
Q1 26
Q4 25
3.53×
Q3 25
3.89×
Q2 25
4.34×
Q1 25
5.36×
Q4 24
5.49×
Q3 24
4.73×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BZH
BZH
SHC
SHC
Operating Cash FlowLast quarter
$103.1M
Free Cash FlowOCF − Capex
$52.4M
FCF MarginFCF / Revenue
17.3%
Capex IntensityCapex / Revenue
16.7%
Cash ConversionOCF / Net Profit
2.96×
TTM Free Cash FlowTrailing 4 quarters
$149.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BZH
BZH
SHC
SHC
Q2 26
Q1 26
Q4 25
$-165.3M
$103.1M
Q3 25
$250.2M
$71.2M
Q2 25
$-62.3M
$57.4M
Q1 25
$3.4M
$55.5M
Q4 24
$-159.4M
$55.7M
Q3 24
$185.4M
$97.5M
Free Cash Flow
BZH
BZH
SHC
SHC
Q2 26
Q1 26
Q4 25
$-170.9M
$52.4M
Q3 25
$242.7M
$35.0M
Q2 25
$-70.2M
$26.2M
Q1 25
$-4.4M
$35.6M
Q4 24
$-164.6M
$-10.2M
Q3 24
$179.8M
$61.1M
FCF Margin
BZH
BZH
SHC
SHC
Q2 26
Q1 26
Q4 25
-47.0%
17.3%
Q3 25
30.6%
11.2%
Q2 25
-12.9%
8.9%
Q1 25
-0.8%
14.0%
Q4 24
-35.1%
-3.5%
Q3 24
22.3%
21.4%
Capex Intensity
BZH
BZH
SHC
SHC
Q2 26
Q1 26
Q4 25
1.5%
16.7%
Q3 25
0.9%
11.6%
Q2 25
1.5%
10.6%
Q1 25
1.4%
7.8%
Q4 24
1.1%
22.7%
Q3 24
0.7%
12.7%
Cash Conversion
BZH
BZH
SHC
SHC
Q2 26
Q1 26
Q4 25
2.96×
Q3 25
8.34×
1.47×
Q2 25
7.21×
Q1 25
0.27×
Q4 24
-50.92×
4.52×
Q3 24
3.56×
5.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BZH
BZH

West region$231.3M56%
East region$90.8M22%
Southeast region$75.7M18%
Land sales and other$12.1M3%

SHC
SHC

Transferred At Point In Time$198.4M65%
Nelson Labs$55.2M18%
Nordion$49.8M16%

Related Comparisons